HiUGE and RMCE for Rapid Stable Cell Line Generation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating stable cell lines are time-consuming and labor-intensive, particularly when producing multiple lines with different genetic alterations, as each line must be carefully characterized to ensure accurate modifications without off-target effects, especially in inducible pluripotent stem cells where isogenic cell lines are desired.
Innovation Solution
The method involves using Homology-independent Universal Genome Engineering (HiUGE) to insert a nucleic acid sequence encoding a donor polypeptide into cells, followed by selection and exchange with a second donor polypeptide via recombination-mediated cassette exchange (RMCE), utilizing recombinase target sites for precise genomic insertion and swapping.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional methods are used to generate stable cell lines with multiple genetic alterations, then each cell line can be carefully characterized to ensure accurate modifications, but the process becomes tedious and time-consuming
Solution Approach 1:
The patent applies preliminary action by pre-inserting recombinase target sites (docking sites) into the genome during an initial HiUGE-mediated integration event. These docking sites remain dormant until a second vector containing the desired genetic alteration and flanked by matching recombinase target sites is introduced. The recombinase enzyme then catalyzes the exchange, allowing rapid generation of multiple cell line variants from a single pre-prepared genomic scaffold, thus reducing overall time while maintaining precision through the specificity of recombinase-DNA interactions.
Solution Approach 2:
The patent segments the genetic modification process into two distinct phases: (1) initial integration of recombinase target sites using HiUGE to create a standardized genomic docking platform, and (2) subsequent rapid exchange of genetic cassettes using recombinase-mediated cassette exchange (RMCE). This segmentation allows the time-consuming characterization to be performed once on the base cell line, while subsequent variants can be generated quickly through controlled recombination events, thereby reducing total time without sacrificing accuracy.
2Reliability
If multiple stable cell lines with different genetic alterations are generated using traditional methods, then each line requires careful characterization to ensure desired modification without off-target effects, but the process becomes labor-intensive
Solution Approach 1:
The patent uses recombinase enzymes as intermediaries to mediate the exchange of genetic cassettes. The recombinase recognizes specific recombinase target sites (such as FRT sites for flippase or loxP sites for Cre recombinase) and catalyzes precise recombination events. This intermediary mechanism ensures high fidelity in genetic modification by directing changes to specific predetermined locations in the genome, reducing off-target effects, and simplifying the production process through controlled, specific recombination events rather than random integration.
Solution Approach 2:
The patent creates a universal genomic platform by inserting recombinase target sites that can accept multiple different genetic cassettes. Once the docking sites are established in the genome, they can universally receive various donor vectors containing different genetic alterations, selectable markers, or protein tags. This multi-functional docking system allows a single cell line to serve as a platform for generating multiple variants, significantly improving ease of manufacture while maintaining reliability through the consistent, specific nature of recombinase-mediated exchange.
3Manufacturing precision
If isogenic cell lines are generated in inducible pluripotent stem cells, then precise genetic modifications are achieved, but the time and effort required for characterization increases significantly
Solution Approach 1:
In the context of iPSCs, the patent applies preliminary action by establishing isogenic cell lines with pre-integrated recombinase target sites using HiUGE, which provides precise targeting capability. These pre-prepared isogenic lines serve as a foundation where the genomic locus is already validated and characterized. Subsequent genetic alterations are introduced through RMCE using the same pre-established docking sites, allowing rapid generation of multiple isogenic variants without repeating the time-consuming validation process, thus reducing characterization time while maintaining the precision required for isogenic cell line generation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables rapid and specific generation of stable cell lines with precise genetic modifications, reducing the time and effort required for characterization and allowing for the creation of isogenic cell lines with various gene or protein fusions, thereby facilitating diverse experimental paradigms.
Implementation Method 1
exchanging the nucleic acid encoding the first donor polypeptide in the genome of the selected cells with a nucleic acid encoding a second donor polypeptide by contacting the selected cells with: (i) a vector comprising a nucleic acid sequence encoding the second donor polypeptide, wherein the nucleic acid encoding the second donor polypeptide is flanked on each side by the one or more recombinase target sites... and (ii) a vector encoding a recombinase that cleaves the one or more recombination target sites inserted into the genome of the selected cells and the one or more recombinase target sites in the vector, whereby the nucleic acid encoding the first donor polypeptide is exchanged for the nucleic acid encoding the second donor polypeptide in the genome of the cells via recombination-mediated cassette exchange (RMCE)
Data Source
AI summary
Provided herein are methods for generating modifiable, stable cell lines.